tiprankstipranks
Trending News
More News >
Innate Pharma SA (IPHYF)
OTHER OTC:IPHYF
US Market
Advertisement

Innate Pharma SA (IPHYF) Technical Analysis

Compare
27 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
2Neutral
3Bearish
Technical Analysis Consensus
Buy
4Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Innate Pharma SA’s (IPHYF) Moving Averages Convergence Divergence (MACD) indicator is 0.14, suggesting Innate Pharma SA is a Buy.
Innate Pharma SA’s (IPHYF) 20-Day exponential moving average is 1.93, while Innate Pharma SA’s (IPHYF) share price is $2.06, making it a Buy.
Innate Pharma SA’s (IPHYF) 50-Day exponential moving average is 1.76, while Innate Pharma SA’s (IPHYF) share price is $2.06, making it a Buy.

Innate Pharma SA (IPHYF) Pivot Points

Sep 06, 2025, 05:15 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.06
2.06
2.06
2.06
2.06
2.06
2.06
Fibonacci
2.06
2.06
2.06
2.06
2.06
2.06
2.06
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Innate Pharma SA (IPHYF) Moving Averages

Sep 06, 2025, 05:15 AM
Period
Simple
Exponential
MA5
2.06Buy
2.06Buy
MA10
2.06Sell
2.04Buy
MA20
1.95Buy
1.93Buy
MA50
1.67Buy
1.76Buy
MA100
1.58Buy
1.78Buy
MA200
2.06Buy
1.97Buy
Innate Pharma SA’s (IPHYF) 10-Day exponential moving average is 2.04, while Innate Pharma SA’s (IPHYF) share price is $2.06, making it a Buy.
Innate Pharma SA’s (IPHYF) 100-Day exponential moving average is 1.78, while Innate Pharma SA’s (IPHYF) share price is $2.06, making it a Buy.
Innate Pharma SA’s (IPHYF) stock price is $2.06 and Innate Pharma SA’s (IPHYF) 50-day simple moving average is 1.67, creating a Buy signal.
Innate Pharma SA’s (IPHYF) stock price is $2.06 and Innate Pharma SA’s (IPHYF) 100-day simple moving average is 1.58, creating a Buy signal.
Innate Pharma SA’s (IPHYF) stock price is $2.06 and Innate Pharma SA’s (IPHYF) 200-day simple moving average is 2.06, creating a Buy signal.

Innate Pharma SA (IPHYF) Technical Indicators

Sep 06, 2025, 05:15 AM
Name
Value
Implied Action
RSI (14)
88.38
Sell
STOCH (9,6)
0.00
Neutral
STOCHRSI (14)
<0.01
Buy
MACD (12,26)
0.14
Buy
ADX (14)
49.93
Neutral
Williams %R
0.13
Sell
CCI (14)
39.22
Neutral
ATR (14)
0.14
-
Ultimate Oscillator
87.46
Buy
ROC
0.00
Buy
Innate Pharma SA’s (IPHYF) Relative Strength Index (RSI) is 88.38, creating a Sell signal.
Innate Pharma SA’s (IPHYF) Trend Strength Indicator (ADX) is 49.93, creating a Neutral signal.
Innate Pharma SA’s (IPHYF) Commodity Channel Index (CCI) is 39.22, creating a Neutral signal.

FAQ

Is IPHYF a Buy, Hold, or Sell?
Based on IPHYF’s technical indicators, IPHYF is a Strong Buy.
    What is IPHYF’s RSI (14)?
    IPHYF’s RSI (14) is 88.38, which suggests IPHYF is a Sell.
      What is IPHYF’s MACD?
      IPHYF’s MACD is 0.14, which suggests IPHYF is a Buy.
        What is IPHYF’s 5-day moving average?
        IPHYF’s 5-day moving average is 2.06, which suggests IPHYF is a Buy.
          What is IPHYF’s 20-day moving average?
          IPHYF 20-day moving average is 1.95, which suggests IPHYF is a Buy.
            What is IPHYF’s 50-day moving average?
            IPHYF’s 50-day moving average is 1.67, which suggests IPHYF is a Buy.
              What is IPHYF’s 200-day moving average?
              IPHYF’s 200-day moving average is 2.06, which suggests IPHYF is a Buy.
                What is IPHYF’s Williams % R (14)?
                IPHYF’s Williams % R (14) is 0.13, which suggests IPHYF is a Sell.
                  What is IPHYF’s CCI (14)?
                  IPHYF’s CCI (14) is 39.22, which suggests IPHYF is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis